Detalhe da pesquisa
1.
American Cancer Society's report on the status of cancer disparities in the United States, 2023.
CA Cancer J Clin
; 74(2): 136-166, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962495
2.
Screening for lung cancer: 2023 guideline update from the American Cancer Society.
CA Cancer J Clin
; 74(1): 50-81, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37909877
3.
Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate resistant prostate cancer.
Stem Cells
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563224
4.
The future of cancer care at home: Findings from an American Cancer Society summit.
CA Cancer J Clin
; 73(4): 353-357, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222235
5.
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
Oncologist
; 28(7): 642-e561, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37134294
6.
A tripartite approach toward ending cancer as we know it, for everyone: An American Cancer Society perspective.
J Surg Oncol
; 128(6): 931-937, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37818915
7.
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide.
Oncologist
; 27(9): 718-e694, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640474
8.
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.
BJU Int
; 127(4): 435-444, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969563
9.
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial.
Lancet Oncol
; 21(8): 1099-1109, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645282
10.
Natural history and imaging in men with high genetic risk for developing prostate cancer.
Can J Urol
; 26(5 Suppl 2): 7-8, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629414
11.
Management Options for Biochemically Recurrent Prostate Cancer.
Curr Treat Options Oncol
; 18(5): 26, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28434181
12.
Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer.
BJU Int
; 118(4): 590-7, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26780387
13.
Metabolic syndrome in prostate cancer: impact on risk and outcomes.
Future Oncol
; 12(16): 1947-55, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27067408
14.
A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.
BJU Int
; 116(4): 546-55, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25407442
15.
A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.
Cancer Immunol Immunother
; 63(4): 407-18, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24514956
16.
Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development.
Expert Opin Emerg Drugs
; 19(4): 459-70, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25345821
17.
Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN.
Oncotarget
; 15: 288-300, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712741
18.
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition.
medRxiv
; 2024 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38370835
19.
Deep Learning-Based Detection and Classification of Bone Lesions on Staging Computed Tomography in Prostate Cancer: A Development Study.
Acad Radiol
; 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262813
20.
Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer.
Cancer Immunol Immunother
; 62(9): 1521-31, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23836412